$LIF
Life360 Inc Stock $lif

$lif Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000158176024000006 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$78.23M	$86.96M	$304.5M
YoY Change	14.8%	21.9%	33.38%
Cost Of Revenue	$18.21M	$26.82M	$81.88M
YoY Change	-0.54%	1.66%	2.73%
Gross Profit	$60.01M	$60.14M	$222.6M
YoY Change	20.44%	33.78%	49.83%
Gross Profit Margin	76.72%	69.15%	73.11%
Selling, General & Admin	$39.13M	$38.46M	$151.7M
YoY Change	4.29%	18.27%	7.92%
% of Gross Profit	65.21%	63.96%	68.12%
Research & Development	$27.26M	$26.02M	$101.0M
YoY Change	0.22%	3.48%	-1.48%
% of Gross Profit	45.42%	43.26%	45.35%
Depreciation & Amortization	$2.295M	$2.449M	$9.141M
YoY Change	0.97%	3.42%	-0.63%
% of Gross Profit	3.82%	4.07%	4.11%
Operating Expenses	$66.39M	$64.48M	$252.6M
YoY Change	2.58%	11.82%	3.95%
Operating Profit	-$6.379M	-$4.341M	-$29.98M
YoY Change	-57.16%	-65.85%	-68.24%
Interest Expense	-$1.707M	$61.00K	-$116.0K
YoY Change	-12292.86%	-45.54%	-108.96%
% of Operating Profit
Other Income/Expense, Net	-$2.004M	$1.545M	$2.428M
YoY Change	-315.72%	194.29%	-21.53%
Pretax Income	-$8.383M	-$2.735M	-$27.56M
YoY Change	-39.96%	-77.35%	-69.82%
Income Tax	$1.400M	$411.0K	$616.0K
% Of Pretax Income
Net Earnings	-$9.777M	-$3.146M	-$28.17M
YoY Change	-30.52%	-74.43%	-69.26%
Net Earnings / Revenue	-12.5%	-3.62%	-9.25%
Basic Earnings Per Share	-$0.14		-$0.42
Diluted Earnings Per Share	-$0.14	-$0.05	-$0.42
COMMON SHARES
Basic Shares Outstanding	68.29M shares	67.71M shares	66.75M shares
Diluted Shares Outstanding	68.54M shares		66.75M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$73.40M	$68.96M	$68.96M
YoY Change	19.56%	-8.59%	-8.59%
Cash & Equivalents	$73.40M	$68.96M	$68.96M
Short-Term Investments
Other Short-Term Assets	$13.22M	$14.52M	$14.52M
YoY Change	-40.8%	-28.12%	-28.12%
Inventory	$6.338M	$4.099M	$4.099M
Prepaid Expenses	$13.22M	$14.52M
Receivables	$37.04M	$42.18M	$43.19M
Other Receivables	$503.0K	$654.0K	$654.0K
Total Short-Term Assets	$131.5M	$131.4M	$131.4M
YoY Change	4.6%	-7.87%	-7.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$684.0K	$730.0K	$1.744M
YoY Change	-9.4%	85.75%	45.94%
Goodwill	$133.7M	$133.7M
YoY Change	0.0%	0.0%
Intangibles		$45.44M
YoY Change		-13.77%
Long-Term Investments
YoY Change
Other Assets	$21.00K	$21.00K	$3.123M
YoY Change	-58.82%	-84.56%	-5.56%
Total Long-Term Assets	$187.3M	$190.3M	$190.3M
YoY Change	-4.16%	-3.39%	-3.39%
TOTAL ASSETS
Total Short-Term Assets	$131.5M	$131.4M	$131.4M
Total Long-Term Assets	$187.3M	$190.3M	$190.3M
Total Assets	$318.8M	$321.7M	$321.7M
YoY Change	-0.73%	-5.27%	-5.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.388M	$5.896M	$5.896M
YoY Change	-1.36%	-57.25%	-57.25%
Accrued Expenses	$19.37M	$16.99M	$16.99M
YoY Change	34.39%	35.55%	35.55%
Deferred Revenue	$35.51M	$33.93M
YoY Change	17.82%	12.9%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.057M	$3.449M	$3.449M
YoY Change	-16.69%	-1.82%	-1.82%
Total Short-Term Liabilities	$74.02M	$70.82M	$70.82M
YoY Change	-8.17%	-19.21%	-19.21%
LONG-TERM LIABILITIES
Long-Term Debt	$1.161M	$1.056M	$1.056M
YoY Change	-58.64%	-73.99%	-73.99%
Other Long-Term Liabilities	$634.0K	$723.0K	$2.782M
YoY Change	27.57%	25.52%	-17.77%
Total Long-Term Liabilities	$634.0K	$723.0K	$3.838M
YoY Change	27.57%	25.52%	-48.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$74.02M	$70.82M	$70.82M
Total Long-Term Liabilities	$634.0K	$723.0K	$3.838M
Total Liabilities	$78.94M	$74.65M	$74.65M
YoY Change	-8.54%	-21.49%	-21.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$294.9M	-$285.1M
YoY Change	8.81%	10.96%
Common Stock	$71.00K	$70.00K
YoY Change	4.41%	4.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$239.8M	$247.1M	$247.1M
YoY Change
Total Liabilities & Shareholders Equity	$318.8M	$321.7M	$321.7M
YoY Change	-0.73%	-5.27%	-5.27%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$9.777M	-$3.146M	-$28.17M
YoY Change	-30.52%	-74.43%	-69.26%
Depreciation, Depletion And Amortization	$2.295M	$2.449M	$9.141M
YoY Change	0.97%	3.42%	-0.63%
Cash From Operating Activities	$10.69M	$8.958M	$7.524M
YoY Change	-216.19%	-515.11%	-113.19%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$989.0K	$506.0K
YoY Change	-100.0%	-100.87%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$26.00K	$0.00
YoY Change		-100.02%	-100.0%
Cash From Investing Activities	-$1.089M	-$963.0K	-$2.221M
YoY Change	191.18%	-139.02%	-98.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.709M	-939.0K	-$24.96M
YoY Change	21.39%	-103.01%	-190.06%
NET CHANGE
Cash From Operating Activities	$10.69M	8.958M	$7.524M
Cash From Investing Activities	-$1.089M	-963.0K	-$2.221M
Cash From Financing Activities	-$5.709M	-939.0K	-$24.96M
Net Change In Cash	$3.890M	7.056M	-$19.65M
YoY Change	-127.25%	-77.59%	-86.06%
FREE CASH FLOW
Cash From Operating Activities	$10.69M	$8.958M	$7.524M
Capital Expenditures	$0.00	$989.0K	$506.0K
Free Cash Flow	$10.69M	$7.969M	$7.018M
YoY Change	-215.86%	-92.84%	-112.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001581760
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 South Norfolk Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 310
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Mateo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94403
CY2023	dei	City Area Code CityAreaCode	415
CY2023	dei	Local Phone Number LocalPhoneNumber	484-5244
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.001 per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	915000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68290623	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68964000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75444000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13274000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42180000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33125000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4099000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10826000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1010000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	131427000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	142655000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1749000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1647000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	730000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	393000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	834000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	626000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	6848000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	7134000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1014000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	802000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45441000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52699000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	133674000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	133674000	usd
CY2023Q4	us-gaap	Assets Assets	321717000	usd
CY2022Q4	us-gaap	Assets Assets	339630000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5896000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13791000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27538000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27015000	usd
CY2023Q4	lifx	Escrow Liability Current EscrowLiabilityCurrent	0	usd
CY2022Q4	lifx	Escrow Liability Current EscrowLiabilityCurrent	13274000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65239843	shares
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38512000	usd
CY2023	lifx	Stockholders Equity Decrease For Interest Accrued Notes Due From Stockholders StockholdersEquityDecreaseForInterestAccruedNotesDueFromStockholders	-40000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91629000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9199000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	876000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2928000	usd
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4014000	usd
CY2023	lifx	Compensation Expense Revesting Notes CompensationExpenseRevestingNotes	73000	usd
CY2023	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	684000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-116000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1608000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100965000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	99072000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	92419000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52583000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48110000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23670000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	252620000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	243009000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	122137000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-94411000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-32262000	usd
CY2021	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	511000	usd
CY2021	lifx	Noncash Adjustment Membership Benefit NoncashAdjustmentMembershipBenefit	0	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2689000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6667000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-10629000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5811000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0197666
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56424
CY2023	dei	Entity Registrant Name EntityRegistrantName	Life360, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	San Francisco, California
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, California
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1438000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15174000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8548000	usd
CY2023Q4	lifx	Convertible Debt Current Fair Value Disclosure ConvertibleDebtCurrentFairValueDisclosure	3449000	usd
CY2022Q4	lifx	Convertible Debt Current Fair Value Disclosure ConvertibleDebtCurrentFairValueDisclosure	3513000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3449000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3513000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	33932000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30056000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70815000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87649000	usd
CY2023Q4	lifx	Convertible Debt Noncurrent Fair Value Disclosure ConvertibleDebtNoncurrentFairValueDisclosure	0	usd
CY2022Q4	lifx	Convertible Debt Noncurrent Fair Value Disclosure ConvertibleDebtNoncurrentFairValueDisclosure	3425000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1056000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4060000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	217000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	101000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1842000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2706000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	723000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	576000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	74653000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	95092000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68155830	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68155830	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65239843	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	70000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	67000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	532128000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	501763000	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	0	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	314000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-285143000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256972000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	247064000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	244538000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321717000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	339630000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	304518000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	228305000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112643000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81881000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	79707000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22768000	usd
CY2023	us-gaap	Gross Profit GrossProfit	222637000	usd
CY2022	us-gaap	Gross Profit GrossProfit	148598000	usd
CY2021	us-gaap	Gross Profit GrossProfit	89875000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102480000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50994000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	47473000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-29983000	usd
CY2023	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	684000	usd
CY2022	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	-1786000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-116000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1295000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-733000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3228000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-178000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2428000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3094000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1422000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27555000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-91317000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33684000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	616000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	312000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-127000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-28171000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91629000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.50
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66748542	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62209545	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51656195	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66748542	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62839593	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51656195	shares
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28156000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91635000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64189000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3543000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4725000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	844000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	603000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	13821000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33557000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5757000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	193064000	usd
CY2021	lifx	Adjustments To Additional Paid In Capital Business Combination Stock Based Compensation Awards Assumed AdjustmentsToAdditionalPaidInCapitalBusinessCombinationStockBasedCompensationAwardsAssumed	533000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11754000	usd
CY2021	lifx	Stockholders Equity Decrease For Interest Accrued Notes Due From Stockholders StockholdersEquityDecreaseForInterestAccruedNotesDueFromStockholders	24000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-33557000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	250045000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2394000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4077000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	15409000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1050000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32215000	usd
CY2022	lifx	Stockholders Equity Repayment Of Notes Receivable From Stockholders StockholdersEquityRepaymentOfNotesReceivableFromStockholders	1296000	usd
CY2022	lifx	Stock Issued During Period Value Settlement Of Contingent Consideration StockIssuedDuringPeriodValueSettlementOfContingentConsideration	4221000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34680000	usd
CY2022	lifx	Stockholders Equity Decrease For Interest Accrued Notes Due From Stockholders StockholdersEquityDecreaseForInterestAccruedNotesDueFromStockholders	11000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91629000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	244538000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5811000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	14033000	usd
CY2023	lifx	Stockholders Equity Repayment Of Notes Receivable From Stockholders StockholdersEquityRepaymentOfNotesReceivableFromStockholders	352000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-28171000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	247064000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-28171000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9141000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2125000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	842000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	38512000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	34680000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	11754000	usd
CY2022	lifx	Compensation Expense Revesting Notes CompensationExpenseRevestingNotes	-87000	usd
CY2021	lifx	Compensation Expense Revesting Notes CompensationExpenseRevestingNotes	184000	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	462000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	474000	usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	166000	usd
CY2022	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	-1786000	usd
CY2021	lifx	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	511000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1295000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-733000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5279000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3600000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1504000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	916000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6474000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	943000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	497000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	859000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1905000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	3343000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1713000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7895000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12654000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	559000	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2193000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-7722000	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4720000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4620000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4660000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1671000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-498000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-303000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1180000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7524000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57055000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12153000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	110933000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2983000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1715000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	701000	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	506000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	81000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2221000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-111634000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7064000	usd
CY2023	lifx	Payments For Escrow Business Acquisition PaymentsForEscrowBusinessAcquisition	13128000	usd
CY2022	lifx	Payments For Escrow Business Acquisition PaymentsForEscrowBusinessAcquisition	0	usd
CY2021	lifx	Payments For Escrow Business Acquisition PaymentsForEscrowBusinessAcquisition	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5811000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2394000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3543000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14033000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4077000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4725000	usd
CY2023	lifx	Proceeds From Collection Of Stockholder Notes Receivable ProceedsFromCollectionOfStockholderNotesReceivable	314000	usd
CY2022	lifx	Proceeds From Collection Of Stockholder Notes Receivable ProceedsFromCollectionOfStockholderNotesReceivable	648000	usd
CY2021	lifx	Proceeds From Collection Of Stockholder Notes Receivable ProceedsFromCollectionOfStockholderNotesReceivable	0	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	41000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1050000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5757000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32215000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193064000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3919000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3471000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	lifx	Proceeds From Advances Received On Convertible Notes ProceedsFromAdvancesReceivedOnConvertibleNotes	0	usd
CY2022	lifx	Proceeds From Advances Received On Convertible Notes ProceedsFromAdvancesReceivedOnConvertibleNotes	0	usd
CY2021	lifx	Proceeds From Advances Received On Convertible Notes ProceedsFromAdvancesReceivedOnConvertibleNotes	2110000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24955000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27709000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	193951000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19652000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-140980000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	174734000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90365000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	231345000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56611000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70713000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90365000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	231345000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	697000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	33000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	640000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	514000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	24000	usd
CY2023	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	15409000	usd
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	13821000	usd
CY2023	lifx	Fair Value Of Warrants Held In Investment FairValueOfWarrantsHeldInInvestment	0	usd
CY2022	lifx	Fair Value Of Warrants Held In Investment FairValueOfWarrantsHeldInInvestment	5474000	usd
CY2021	lifx	Fair Value Of Warrants Held In Investment FairValueOfWarrantsHeldInInvestment	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	4221000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1054000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	lifx	Operating Lease Liability Recognized Lease Modification OperatingLeaseLiabilityRecognizedLeaseModification	1054000	usd
CY2022	lifx	Operating Lease Liability Recognized Lease Modification OperatingLeaseLiabilityRecognizedLeaseModification	0	usd
CY2021	lifx	Operating Lease Liability Recognized Lease Modification OperatingLeaseLiabilityRecognizedLeaseModification	0	usd
CY2023	lifx	Noncash Or Part Noncash Acquisition Debt Issued NoncashOrPartNoncashAcquisitionDebtIssued	0	usd
CY2022	lifx	Noncash Or Part Noncash Acquisition Debt Issued NoncashOrPartNoncashAcquisitionDebtIssued	0	usd
CY2021	lifx	Noncash Or Part Noncash Acquisition Debt Issued NoncashOrPartNoncashAcquisitionDebtIssued	11597000	usd
CY2023	lifx	Noncash Or Part Noncash Acquisition Contingent Consideration Issued NoncashOrPartNoncashAcquisitionContingentConsiderationIssued	0	usd
CY2022	lifx	Noncash Or Part Noncash Acquisition Contingent Consideration Issued NoncashOrPartNoncashAcquisitionContingentConsiderationIssued	0	usd
CY2021	lifx	Noncash Or Part Noncash Acquisition Contingent Consideration Issued NoncashOrPartNoncashAcquisitionContingentConsiderationIssued	5900000	usd
CY2023	lifx	Noncash Or Part Noncash Acquisition Stock Based Compensation Assumed NoncashOrPartNoncashAcquisitionStockBasedCompensationAssumed	0	usd
CY2022	lifx	Noncash Or Part Noncash Acquisition Stock Based Compensation Assumed NoncashOrPartNoncashAcquisitionStockBasedCompensationAssumed	0	usd
CY2021	lifx	Noncash Or Part Noncash Acquisition Stock Based Compensation Assumed NoncashOrPartNoncashAcquisitionStockBasedCompensationAssumed	533000	usd
CY2023	lifx	Warrants Issued WarrantsIssued	0	usd
CY2022	lifx	Warrants Issued WarrantsIssued	0	usd
CY2021	lifx	Warrants Issued WarrantsIssued	844000	usd
CY2023	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	usd
CY2022	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	usd
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	4023000	usd
CY2023	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	usd
CY2022	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	usd
CY2021	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	603000	usd
CY2023	lifx	Convertible Debt Embedded Derivative Bifurcated ConvertibleDebtEmbeddedDerivativeBifurcated	0	usd
CY2022	lifx	Convertible Debt Embedded Derivative Bifurcated ConvertibleDebtEmbeddedDerivativeBifurcated	0	usd
CY2021	lifx	Convertible Debt Embedded Derivative Bifurcated ConvertibleDebtEmbeddedDerivativeBifurcated	663000	usd
CY2023	lifx	Noncash Investing And Financing Activities NoncashInvestingAndFinancingActivities	2108000	usd
CY2022	lifx	Noncash Investing And Financing Activities NoncashInvestingAndFinancingActivities	25104000	usd
CY2021	lifx	Noncash Investing And Financing Activities NoncashInvestingAndFinancingActivities	37984000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68964000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75444000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	230990000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13274000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1749000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1647000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	355000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70713000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90365000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	231345000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life360, Inc. is a leading technology platform used to locate the people, pets and things that matter most to families. The Company was incorporated in the State of Delaware in 2007. The Company’s core offering, the Life360 mobile application, includes features that range from communications to driving safety and location sharing. The Company operates under a “freemium” model where its core offering is available to users at no charge, with three membership subscription options that are available but not required. The Company also generates revenue through Jiobit and Tile subscription services and hardware tracking devices and monetization arrangements with certain commercial third parties (“Data Revenue Partners”) through Lead Generation and license agreements including aggregated insights into the data collected from the Company’s user base.</span></div>
CY2023	lifx	Number Of Membership Subscription Options NumberOfMembershipSubscriptionOptions	3	subscriptionoption
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div>The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Significant estimates made by management include, but are not limited to, the determination of revenue recognition, including the determination of selling prices for distinct performance obligations sold in multiple-performance obligation arrangements, the period over which revenue is recognized for certain arrangements, and estimated delivery dates for orders with title transfer upon delivery, allowance for credit losses, product returns, promotional and marketing allowances, inventory valuation, average useful customer life, stock-based compensation, legal contingencies, assessment of possible impairment of long-lived assets and goodwill, valuation of contingent consideration, convertible notes and embedded derivatives, useful lives of long lived assets and income taxes including valuation allowances on deferred tax assets. The Company bases its estimates and judgments on historical experience and on various assumptions that it believes are reasonable under the circumstances. Actual results could differ significantly from those estimates.
CY2022Q1	lifx	Revenue Partnership Agreement Term RevenuePartnershipAgreementTerm	P3Y
CY2023	lifx	Extended Product Warranty Term ExtendedProductWarrantyTerm	P3Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	67900000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.85
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023	us-gaap	Advertising Expense AdvertisingExpense	28600000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	17000000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	7100000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	1700000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1700000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1600000	usd
CY2023	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1700000	usd
CY2022	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	700000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.14
CY2023	us-gaap	Restructuring Charges RestructuringCharges	4000000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	4024000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	5500000	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	5500000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	304518000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	228305000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112643000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32762000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13929000	usd
CY2023	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
CY2022	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	10203000	usd
CY2023	lifx	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	229871000	usd
CY2022	lifx	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	213748000	usd
CY2023	lifx	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	226859000	usd
CY2022	lifx	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	205118000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	35774000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32762000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	30100000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13900000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2064000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1649000	usd
CY2023	lifx	Capitalized Contract Cost Increase For Contract Acquired In Business Combination CapitalizedContractCostIncreaseForContractAcquiredInBusinessCombination	0	usd
CY2022	lifx	Capitalized Contract Cost Increase For Contract Acquired In Business Combination CapitalizedContractCostIncreaseForContractAcquiredInBusinessCombination	1184000	usd
CY2023	lifx	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	1905000	usd
CY2022	lifx	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	2159000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2125000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2928000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1844000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2064000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	41981000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	41981000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	217000	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3449000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3666000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	61227000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	61227000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	101000	usd
CY2022Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	6938000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7039000	usd
CY2021Q3	lifx	Retention Bonuses Vesting Period RetentionBonusesVestingPeriod	P24M
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5300000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3600000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	42274000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	33219000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	94000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	94000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42180000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33125000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	298000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3063000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3801000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7763000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4099000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10826000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	900000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	14520000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6925000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	654000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1623000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15174000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8548000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1514000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1009000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	784000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	616000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	730000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	393000	usd
CY2023	us-gaap	Depreciation Depreciation	100000	usd
CY2022	us-gaap	Depreciation Depreciation	500000	usd
CY2021	us-gaap	Depreciation Depreciation	500000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1353000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1524000	usd
CY2023Q4	us-gaap	Investments Investments	5474000	usd
CY2022Q4	us-gaap	Investments Investments	5474000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	6848000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	7134000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y10M24D
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1100000	usd
CY2023Q2	lifx	Operating Lease Liability Recognized Lease Modification OperatingLeaseLiabilityRecognizedLeaseModification	1100000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	924000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2345000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1470000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	900000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1014000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	802000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	335000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	813000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	723000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	379000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	390000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	367000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1136000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	78000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1058000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	63516000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18075000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45441000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	61801000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9102000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52699000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8700000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9472000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8891000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4328000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4225000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9079000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45441000	usd
CY2023Q4	lifx	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	10020000	usd
CY2022Q4	lifx	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	4868000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3349000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3900000	usd
CY2023Q4	lifx	Customer Related Promotions And Discounts Payable Current CustomerRelatedPromotionsAndDiscountsPayableCurrent	9049000	usd
CY2022Q4	lifx	Customer Related Promotions And Discounts Payable Current CustomerRelatedPromotionsAndDiscountsPayableCurrent	10871000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	335000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	813000	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	3285000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	2952000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1500000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3611000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27538000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27015000	usd
CY2023Q4	lifx	Deposit Liabilities Noncurrent DepositLiabilitiesNoncurrent	0	usd
CY2022Q4	lifx	Deposit Liabilities Noncurrent DepositLiabilitiesNoncurrent	78000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	498000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	723000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	723000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	576000	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	700000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	4505000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	7573000	usd
CY2023Q4	lifx	Common Stock Subject To Repurchase CommonStockSubjectToRepurchase	108592	shares
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2645503	shares
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3365000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2110000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2023Q4	lifx	Long Term Debt Before Fair Value Adjustment LongTermDebtBeforeFairValueAdjustment	5475000	usd
CY2023Q4	lifx	Long Term Debt Fair Value Adjustment LongTermDebtFairValueAdjustment	-970000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4505000	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	700000	usd
CY2022	lifx	Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	derivative liability
CY2023	lifx	Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	derivative liability
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	200000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	100000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	29727000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	25000000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	25500000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	26000000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	106227000	usd
CY2022Q4	lifx	Common Stock Subject To Repurchase CommonStockSubjectToRepurchase	108592	shares
CY2022Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	33300000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	30154209	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16011495	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	137658	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	137658	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8180840	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.05
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M9D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40827000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	935045	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.25
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	619983	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.15
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6625812	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.57
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M4D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	59957000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5506657	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.54
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	55258000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	23246474	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	16882215	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.33
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.65
CY2023Q4	lifx	Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValue	15.46
CY2022Q4	lifx	Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValue	9.94
CY2021Q4	lifx	Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValue	21.16
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.03
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7700000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4100000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15100000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5800000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	29300000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	80600000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38512000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34680000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11938000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-27100000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	300000	usd
CY2023	lifx	Income Tax Expense Benefit Excluding Adjustments For Timing Differences IncomeTaxExpenseBenefitExcludingAdjustmentsForTimingDifferences	600000	usd
CY2022	lifx	Income Tax Expense Benefit Excluding Adjustments For Timing Differences IncomeTaxExpenseBenefitExcludingAdjustmentsForTimingDifferences	100000	usd
CY2021	lifx	Income Tax Expense Benefit Excluding Adjustments For Timing Differences IncomeTaxExpenseBenefitExcludingAdjustmentsForTimingDifferences	-100000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-27400	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-100000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.02
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.06
CY2023	lifx	Effective Income Tax Rate Reconciliation Fair Value Adjustment Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentPercent	-0.01
CY2022	lifx	Effective Income Tax Rate Reconciliation Fair Value Adjustment Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentPercent	0.02
CY2021	lifx	Effective Income Tax Rate Reconciliation Fair Value Adjustment Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentPercent	-0.03
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.01
CY2023	lifx	Effective Income Tax Rate Reconciliation Officer Compensation Percent EffectiveIncomeTaxRateReconciliationOfficerCompensationPercent	0.10
CY2022	lifx	Effective Income Tax Rate Reconciliation Officer Compensation Percent EffectiveIncomeTaxRateReconciliationOfficerCompensationPercent	0
CY2021	lifx	Effective Income Tax Rate Reconciliation Officer Compensation Percent EffectiveIncomeTaxRateReconciliationOfficerCompensationPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.14
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1002000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2534000	usd
CY2023Q4	lifx	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	259000	usd
CY2022Q4	lifx	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	213000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	162000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	281000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	46877000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62565000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4359000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6353000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	39112000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	21170000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12651000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9569000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	104422000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	102685000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	250000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	210000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	10073000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	12829000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10323000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13039000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94099000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	89646000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4500000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	42700000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4588000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1327000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5176000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11091000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	968000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12059000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28171000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91629000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33557000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66748542	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62209545	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51656195	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28171000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91629000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33557000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-28171000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-94195000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33557000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66748542	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62209545	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51656195	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66748542	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62839593	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51656195	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.50
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13271994	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15098390	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10454425	shares

Files In Submission

Name	View Source	Status
0001581760-24-000006-index-headers.html	Edgar Link	pending
0001581760-24-000006-index.html	Edgar Link	pending
0001581760-24-000006.txt	Edgar Link	pending
0001581760-24-000006-xbrl.zip	Edgar Link	pending
exhibit1012amendmentno1tod.htm	Edgar Link	pending
exhibit1026-life360xnedapp.htm	Edgar Link	pending
exhibit103-life360fy23xlif.htm	Edgar Link	pending
exhibit104-life360fy23xfor.htm	Edgar Link	pending
exhibit231fy23dtconsent.htm	Edgar Link	pending
exhibit232bdoconsent.htm	Edgar Link	pending
exhibit311-life360fy23xceo.htm	Edgar Link	pending
exhibit312-life360fy23xcfo.htm	Edgar Link	pending
exhibit321-life360fy23xceo.htm	Edgar Link	pending
exhibit322-life360fy23xcfo.htm	Edgar Link	pending
exhibit42descriptionofcapi.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
image_1.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
lifx-20231231.htm	Edgar Link	pending
lifx-20231231.xsd	Edgar Link	pending
lifx-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
lifx-20231231_def.xml	Edgar Link	unprocessable
lifx-20231231_lab.xml	Edgar Link	unprocessable
lifx-20231231_pre.xml	Edgar Link	unprocessable
lifx-20231231_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lifx-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIF
Life360 Inc Stock $lif

2024 Q1 Form 10-K Financial Statement

#000158176024000006 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIF Life360 Inc Stock $lif

2024 Q1 Form 10-K Financial Statement

#000158176024000006 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIF
Life360 Inc Stock $lif